The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension
Open accessAbstract
We sought to compare the risk of end-stage renal disease (ESRD), ischemic heart event (IHE), congestive heart failure (CHF), cerebrovascular accident (CVA), and all-cause mortality among 470,386 individuals with resistant and nonresistant hypertension (non-RH). Resistant hypertension (60,327 individuals) was subcategorized into two groups: 23,104 patients with cRH (controlled on four or more medicines) and 37,223 patients with uRH (uncontrolled on three or more medicines) in a 5-year retrospective cohort study. Cox proportional hazard modeling was used to estimate hazard ratios adjusting for age, gender, race, body mass index, chronic kidney disease (CKD), and comorbidities. Resistant hypertension (cRH and uRH), compared with non-RH, had multivariable adjusted hazard ratios (95% confidence intervals) of 1.32 (1.27-1.37), 1.24 (1.20-1.28), 1.46 (1.40-1.52), 1.14 (1.10-1.19), and 1.06 (1.03-1.08) for ESRD, IHE, CHF, CVA, and mortality, respectively. Comparison of uRH with cRH had hazard ratios of 1.25 (1.18-1.33), 1.04 (0.99-1.10), 0.94 (0.89-1.01), 1.23 (1.14-1.31), and 1.01 (0.97-1.05) for ESRD, IHE, CHF, CVA, and mortality, respectively. Men and Hispanics had a greater risk for ESRD within all three cohorts. Individuals with resistant hypertension had a greater risk for ESRD, IHE, CHF, CVA, and mortality. The risk of ESRD and CVA were 25% and 23% greater, respectively, in uRH compared with cRH, supporting the linkage between blood pressure and both outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of RH is underscored by the associated risk of adverse outcomes compared with non-RH.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
Self-citationUS trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O’Donnell, C. J., Kannel, W. B., & Levy, D. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003417 · Cited by 2,098
Cited by
Sorted by citations
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Self-citationTreatment of Resistant and Refractory Hypertension
Acelajado, M. C., Hughes, Z. H., Oparil, S., & Calhoun, D. A. (2019) · Circulation Research · doi:10.1161/circresaha.118.312156 · Cited by 226
Self-citationHamrahian, S. M., Maarouf, O. H., & Fülöp, T. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s368784 · Cited by 212
Thomas, G., Xie, D., Chen, H.-Y., Anderson, A. H., Appel, L. J., Bodana, S., Brecklin, C. S., Drawz, P., Flack, J. M., Miller, E. R., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06487 · Cited by 190
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Chemical and Biological Properties of S-1-Propenyl-ʟ-Cysteine in Aged Garlic Extract
Kodera, Y., Ushijima, M., Amano, H., Suzuki, J., & Matsutomo, T. (2017) · Molecules · doi:10.3390/molecules22040570 · Cited by 99
Brazilian Guidelines of Hypertension – 2025
Brandão, A. A., Rodrigues, C. I. S., Bortolotto, L. A., Armstrong, A. D. C., Mulinari, R. A., Feitosa, A. D. M., Gomes, M. A. M., Barbosa, E. C. D., Moura-Neto, J. A., Neves, M. F., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250624 · Cited by 102
Resistant Hypertension: Novel Insights
Lamirault, G., Artifoni, M., Daniel, M., Barber‐Chamoux, N., & Nantes University Hospital Working Group on Hypertension (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666191011111402 · Cited by 96
Spironolactone versus sympathetic renal denervation to treat true resistant hypertension
Oliveras, A., Armario, P., Clarà, A. B. I., Atxer, L. S., González, S. V., Pascual, J., & de la Sierra, A. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001025 · Cited by 81
Resistant Hypertension in People With CKD: A Review
Fay, K., & Cohen, D. L. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.04.017 · Cited by 80
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 91
Hypertension: Current trends and future perspectives
Hunter, P. G., Chapman, F. A., & Dhaun, N. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14825 · Cited by 79
Shlyakhto, E. V., Звартау, Н. Э., Вадимовна, В. С., Yakovlev, A. N., Soloveva, A. E., Alieva, A. S., Avdonina, N. G., Медведева, Е. А., Федоренко, А. А., Владимирович, К. В., et al. (2019) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2019-11-69-82 · Cited by 71
The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors
Ancker, O. V., Wehland, M., Bauer, J. W., Infanger, M., & Grimm, D. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030625 · Cited by 62
Diagnosis and management of resistant hypertension
Schiffrin, E. L., & Fisher, N. D. L. (2024) · BMJ · doi:10.1136/bmj-2023-079108 · Cited by 64
Medication adherence and treatment-resistant hypertension: a review
Hameed, M. A., & Dasgupta, I. (2019) · Drugs in Context · doi:10.7573/dic.212560 · Cited by 62
The Burden of Resistant Hypertension Across the World
Brant, L. C. C., Passaglia, L. G., Filho, M. M. P., de Castilho, F. M., Ribeiro, A. L. P., & Nascimento, B. R. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01173-w · Cited by 57
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
Bioletto, F., Bollati, M., Lopez, C., Arata, S., Procopio, M., Ponzetto, F., Ghigo, E., Maccario, M., & Parasiliti‐Caprino, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094803 · Cited by 55
Cai, A., & Calhoun, D. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.08929 · Cited by 54
Self-citationLawson, A. J., Hameed, M. A., Brown, R., Cappuccio, F. P., George, S., Hinton, T., Kapil, V., Lenart, J., Lobo, M. D., Martin, U., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002398 · Cited by 55
Medication Non-adherence: a Major Cause of Resistant Hypertension
Hamrahian, S. M. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01400-3 · Cited by 61
Kaczmarski, K., Sozio, S. M., Chen, J., Sang, Y., & Shafi, T. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1315-0 · Cited by 52
Kobayashi, M., Pitt, B., Ferreira, J. P., Rossignol, P., Girerd, N., & Zannad, F. M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf225 · Cited by 51
Matsutomo, T., Ushijima, M., Kodera, Y., Nakamoto, M., Takashima, M., Morihara, N., & Tamura, K. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.01.029 · Cited by 48
Tian, Z., Barbosa, C. V., Lang, H., Bauersachs, J. K., Melk, A., & Schmidt, B. M. W. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad165 · Cited by 44
What is resistant arterial hypertension?
Shalaeva, E. V., & Messerli, F. H. (2023) · Blood Pressure · doi:10.1080/08037051.2023.2185457 · Cited by 45
Wang, M., Li, J., Li, Y., Yao, S., Zhao, M., Wang, C., Wu, S., & Xue, H. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13768 · Cited by 41
Ebinger, J. E., Kauko, A., FinnGen, Bello, N. A., Cheng, S. C., & Niiranen, T. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad066 · Cited by 40
Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
Schmieder, R. E. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac189 · Cited by 39
Diagnosis and management of resistant hypertension: state of the art
Wei, F.-F., Zhang, Z.-Y., Huang, Q.-F., & Staessen, J. A. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0006-6 · Cited by 39
Low Systolic Blood Pressure From Treatment and Association With Serious Falls/Syncope
Sim, J. J., Zhou, H. C., Bhandari, S. K., Wei, R. X., Brettler, J., Tran-Nguyen, J., Handler, J., Shimbo, D., Jacobsen, S. J., & Reynolds, K. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.05.026 · Cited by 37
Self-citationRefractory versus resistant hypertension: Novel distinctive phenotypes.
Dudenbostel, T., Siddiqui, M., Gharpure, N., & Calhoun, D. A. (2017) · PubMed · Cited by 34
Self-citationViazzi, F. C., Piscitelli, P. A., Ceriello, A., Fioretto, P., Giorda, C. B., Guida, P., Russo, G. T., Cosmo, S. D., Pontremoli, R., & AMD‐Annals Study Group (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006745 · Cited by 34
Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment
van Schoonhoven, A. V., van Asselt, A. D. I., Tomaszewski, M., Patel, P., Khunti, K. K., Gupta, P., & Postma, M. J. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11227 · Cited by 32
Kuang, T.-M. T., Xirasagar, S., Kao, Y., Shia, B., & Lin, H. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.04.020 · Cited by 30
The Global Burden of Resistant Hypertension and Potential Treatment Options
Buso, G., Rosei, C. A., Lemoli, M., Corvini, F., & Muiesan, M. L. (2024) · European Cardiology Review · doi:10.15420/ecr.2023.51 · Cited by 30
When blood pressure refuses to budge: exploring the complexity of resistant hypertension
Champaneria, M. K., Patel, R., & Oroszi, T. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1211199 · Cited by 30
Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
Yugar‐Toledo, J. C., Moreno, H., Gus, M., Rosito, G. B. A., Scala, L. C. N., Muxfeldt, E. S., Alessi, A., Brandão, A. A., Filho, O. M., Feitosa, A. D. M., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200198 · Cited by 33
Владимировна, А. А., Анатольевна, С. О., Blinova, N. V., Danilov, N. M., Elfimova, E. M., Кislyak, O. A., Litvin, A. Y., Ощепкова, Е. В., Fomin, V. V., Михайловна, Ч. Н., et al. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.09.201007 · Cited by 29
Marin, F., Fezzi, S., Gambaro, A., Ederle, F., Castaldi, G., Widmann, M., Gangemi, C., Ferrero, V., Pesarini, G., Pighi, M., et al. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-00966-7 · Cited by 27
Metabolic Syndrome-Related Features in Controlled and Resistant Hypertensive Subjects
Catharina, A. S., Modolo, R., Ritter, A. M. V., Sabbatini, A. R., Lopes, H. F., Moreno, H., & de Faria, A. P. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180076 · Cited by 28
Novel pharmacological approaches to lowering blood pressure and managing hypertension
Sayer, M., Webb, D. J., & Dhaun, N. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01131-4 · Cited by 26
Yoon, M., You, S. C., Oh, J., Lee, C. J., Lee, S., Kang, S., & Park, S. (2022) · Hypertension Research · doi:10.1038/s41440-021-00845-5 · Cited by 24
New trials in resistant hypertension: mixed blessing stories
Zoccali, C., Mallamaci, F., Nicola, L. D., & Minutolo, R. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad251 · Cited by 24
Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison
Wolley, M. J., & Stowasser, M. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0641-x · Cited by 24
Viazzi, F. C., Greco, E., Ceriello, A., Fioretto, P., Giorda, C. B., Guida, P., Russo, G. T., Cosmo, S. D., Pontremoli, R., & AMD-Annals Study Group (2018) · Kidney & Blood Pressure Research · doi:10.1159/000488255 · Cited by 24
Resistant Hypertension and Mortality: An Observational Cohort Study
de la Sierra, A., Ruilope, L. M., Staplin, N., Gorostidi, M., Vinyoles, E., Segura, J., Armario, P., Oliveras, A., & Williams, B. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23276 · Cited by 26
Lithovius, R., Harjutsalo, V., Mutter, S., Gordin, D., Forsblom, C. M., Groop, P., & FinnDiane Study Group (2020) · Diabetes Care · doi:10.2337/dc20-0170 · Cited by 23
Special Article - The management of resistant hypertension: A 2020 update
Carey, R. M. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.08.001 · Cited by 23
Optimizing identification of resistant hypertension: Computable phenotype development and validation
McDonough, C. W., Babcock, K., Chucri, K., Crawford, D. C., Bian, J., Modave, F. P., Cooper‐DeHoff, R. M., & Hogan, W. R. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5095 · Cited by 22
Faconti, L., George, J., Partridge, S., Maniero, C., Sathyanarayanan, A., Kulkarni, S., Kapil, V., Petrosino, A., Lewis, P., McCormack, T., et al. (2024) · Journal of Human Hypertension · doi:10.1038/s41371-024-00983-6 · Cited by 23
Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure
Cavalcante, G. L., Brognara, F., Oliveira, L. V. D. C., Lataro, R. M., Durand, M., de Oliveira, A. P., da Nóbrega, A. C. L., Salgado, H. C., & Sabino, J. P. J. (2021) · Acta Physiologica · doi:10.1111/apha.13663 · Cited by 22
Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation
Azzam, O., Nejad, S. H., Carnagarin, R., Nolde, J. M., Kiuchi, M. G., & Schlaich, M. P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16247 · Cited by 21
Emerging concepts for patients with treatment-resistant hypertension
Eirin, A., Textor, S. C., & Lerman, L. O. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.05.004 · Cited by 21
on behalf of the Spanish Sleep Network, Navarro‐Soriano, C., Martínez‐García, M. Á., Torres, G., Barbé, F., Caballero‐Eraso, C., Lloberes, P., Díaz-Cambriles, T., Somoza, M., Masa, J. F., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0285-8 · Cited by 21
Self-citationResistant Hypertension Updated Guidelines
Chernova, I., & Krishnan, N. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1209-6 · Cited by 21
Cardoso, C. R. L., Leite, N. C., Bacan, G., Santos, D. A., Gorgonio, L. K. C., & Salles, G. F. (2019) · Diabetes Care · doi:10.2337/dc19-1534 · Cited by 21
Role of home blood pressure monitoring in resistant hypertension
Kim, H. M., & Shin, J. (2023) · Clinical Hypertension · doi:10.1186/s40885-022-00226-1 · Cited by 20
Jafari, E. A., Cooper‐DeHoff, R. M., Effron, M. B., Hogan, W. R., & McDonough, C. W. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad084 · Cited by 20
van der Sande, N. G. C., de Beus, E., Bots, M. L., Voskuil, M., Blankestijn, P. J., Visseren, F. L. J., & Spiering, W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001494 · Cited by 19
Zhao, Y., Zhu, J., Liang, H., Yang, S., Zhang, Y., Han, W., Chen, C., Cao, N., Aruhan, Liang, P., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01548 · Cited by 19
Flack, J. M., Azizi, M., Brown, J. M., Dwyer, J. P., Jones, E. S. W., Lihn, A. S., Liu, L., Olsson, D. S., Perl, S., Shibata, H., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02297-7 · Cited by 19
Wijkman, M. O., Malachias, M. V. B., Claggett, B. L., Cheng, S. C., Matsushita, K., Shah, A. M., Jhund, P. S., Coresh, J., Solomon, S. D., & Vardeny, O. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14269 · Cited by 18
Bakris, G. L., Chen, C., Campbell, A. K., Ashton, V., Haskell, L. P., & Singhal, M. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14701 · Cited by 18
Lifestyle Medicine as a Treatment for Resistant Hypertension
Ribeiro, F., Teixeira, M., Alves, A. J., Sherwood, A., & Blumenthal, J. A. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01253-5 · Cited by 19
Nejad, S. H., Azzam, O., & Schlaich, M. P. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01259-z · Cited by 18
Diagnosis and management of resistant hypertension
Camafort, M., Kreutz, R. H., & Cho, M. (2023) · Heart · doi:10.1136/heartjnl-2022-321730 · Cited by 17
Cabrini, M. L., Macedo, T. A., Castro, E. F. D. S. E., de Barros, S., Azam, I. F. B., Pio-Abreu, A., da Silva, G. V., Lorenzi‐Filho, G., Bortolotto, L. A., & Drager, L. F. (2023) · Hypertension Research · doi:10.1038/s41440-023-01320-z · Cited by 17
Bhandari, S. K., Shi, J. M., Molnar, M. Z., Rasgon, S. A., Derose, S. F., Kovesdy, C. P., Calhoun, D. A., Kalantar‐Zadeh, K., Jacobsen, S. J., & Sim, J. J. (2016) · Respirology · doi:10.1111/resp.12840 · Cited by 16
Self-citationBarochiner, J., Aparicio, L. S., Martínez, R., Alfie, J., & Marín, M. J. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002913 · Cited by 16
Big data in nephrology: promises and pitfalls
Nadkarni, G. N., Coca, S. G., & Wyatt, C. M. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.003 · Cited by 16
Oliveras, A., Armario, P., Sans, L., Clarà, A. B. I., González, S. V., Molina, L., Pareja, J., de la Sierra, A., & Pascual, J. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13156 · Cited by 15
Österreichischer Blutdruckkonsens 2019
Hypertensiologie, Ö. G. F., Weber, T., Atherosklerosegesellschaft, Ö., Gesellschaft, Ö. D., Angiologie, Ö. G. F. I., Nephrologie, Ö. G. F., Gesellschaft, Ö. K., Neurologie, Ö. G. F., Schlaganfall-Gesellschaft, Ö., Allgemeinmedizin, Ö. G. F., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-01565-0 · Cited by 15
Kasiakogias, A., Tsioufis, C. P., Dimitriadis, K. S., Konstantinidis, D., Koumelli, A., Leontsinis, I., Andrikou, E., Vogiatzakis, N., Marinaki, S., Petras, D. I., et al. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0065-y · Cited by 14
Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension
Li, W., Gong, M., Yu, Q., Liu, R., Chen, K., Lv, W., Yao, F., Xu, Z., Xu, Y., Song, W., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14454 · Cited by 14
Zhu, B., Liu, Y., Zhou, W., Du, Y., Qi, D., Wang, C., Cheng, Q., Zhang, Y., Wang, S., & Gao, C. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14651 · Cited by 14
An, J., Sim, J. J., Calhoun, D. A., Liu, R., Wei, R. X., Zhou, H. C., Luong, T. Q., & Reynolds, K. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002419 · Cited by 14
Self-citationThe many faces of hypertension in individuals with type 1 diabetes
Lithovius, R., & Groop, P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110564 · Cited by 15
Resistant hypertension: Renal denervation or intensified medical treatment?
Morganti, A., & Mancia, G. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.12.010 · Cited by 13
Touis, L. Z., Bolbrinker, J., Riemer, T., & Kreutz, R. H. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022026 · Cited by 13
Groenland, E. H., Bots, M. L., Asselbergs, F. W., de Borst, G. J., Kappelle, L. J., Visseren, F. L. J., & Spiering, W. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.04.047 · Cited by 13
Holtrop, J., Spiering, W., Nathoe, H. M., de Borst, G. J., Kappelle, L. J., de Valk, H. W., Visseren, F. L. J., & Westerink, J. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002227 · Cited by 13
Aprocitentan: a new emerging prospect in the pharmacotherapy of hypertension
Naseralallah, L. M. A., & Koraysh, S. (2024) · Blood Pressure · doi:10.1080/08037051.2024.2424824 · Cited by 12
de Beus, E., van der Sande, N. G. C., Bots, M. L., Spiering, W., Voskuil, M., Visseren, F. L. J., & Blankestijn, P. J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016692 · Cited by 12
Chun, K., Lee, C. J., Oh, J., Lee, S., Kang, S., Kario, K., & Park, S. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14043 · Cited by 12
Altered gut microbiota and metabolite profiles provide clues in understanding resistant hypertension
Guo, J., Jia, P., Gu, Z., Tang, W., Ai, W., Sun, Y., & Li, Z. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003716 · Cited by 11
Chattranukulchai, P., Roubsanthisuk, W., Kunanon, S., Kotruchin, P., Satirapoj, B., Wongpraparut, N., Sunthornyothin, S., & Sukonthasarn, A. (2024) · Hypertension Research · doi:10.1038/s41440-024-01785-6 · Cited by 11
Aprocitentan for Blood Pressure Reduction in Black Patients
Flack, J. M., Schlaich, M. P., Weber, M. A., Sassi-Sayadi, M., Narkiewicz, K., Clozel, M., Dreier, R. F., Andrawis, N. S., Danaietash, P., Gabra, N., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.24142 · Cited by 11
Leiba, A., Yekutiel, N., Chodick, G., Wortsman, J., Angel-Korman, A., & Weinreb, B. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00749-y · Cited by 11
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives
Scalise, F., Quarti‐Trevano, F., Toscano, E., Sorropago, A., Vanoli, J., & Grassi, G. M. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-023-00621-1 · Cited by 11
Drummond, H. A. (2021) · Physiology · doi:10.1152/physiol.00008.2021 · Cited by 11
Torres, G., Sánchez‐de‐la‐Torre, M., Gràcia‐Lavedan, E., Benitez, I. D., Martínez, D., Dalmases, M., Pinilla, L., Mínguez, O., Vaca, R., Pascual, L., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.00269-2024 · Cited by 11
Prognosis of apparent treatment-resistant hypertension and poor adherence: a nationwide cohort study
Lee, C. J., Lee, H., Seo, J., Hwang, J., Kang, D., Park, S., Hwang, J., Park, J. H., & Park, S. (2024) · Hypertension Research · doi:10.1038/s41440-024-01988-x · Cited by 10
Manickavasagar, R., Krishnan, A., Azzam, O., & Schlaich, M. P. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02262-3 · Cited by 10
Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation
Townsend, R. R., Agiro, A., Luan, S., Brzozowski, K., Moyneur, É., Tétreault-Langlois, P., & Huang, J. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf183 · Cited by 10
Yusuf, I. A., Badero, O. J., Ihesiulo, A., Okwah, M. N., Oshodin, A. T.-E., & Asikong, E. (2026) · PLoS ONE · doi:10.1371/journal.pone.0349932 · Cited by 10
Adams, A. L., Li, B. H., Bhandari, S., Kamat, S., Sundar, S. V., Krasa, H. B., Rhee, C. M., Kalantar‐Zadeh, K., Jacobsen, S. J., & Sim, J. J. (2019) · Osteoporosis International · doi:10.1007/s00198-018-04832-4 · Cited by 10
Self-citationfor the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Solini, A., Penno, G., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Lamacchia, O., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1313-x · Cited by 10
Renal denervation: Alternative treatment options for hypertension?
Gupta, A. A., Prince, M., Bob‐Manuel, T., & Jenkins, J. S. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.12.007 · Cited by 10
Nakamaru, R., Yamamoto, K. I., Rakugi, H., Akasaka, H., Kurihara, I., Ichijo, T., Takeda, Y., Katabami, T., Tsuiki, M., Wada, N., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14203 · Cited by 10
Metadata
- Authors
- Sim, J. J., Bhandari, S. K., Shi, J., Reynolds, K., Calhoun, D. A., Kalantar-Zadeh, K., & Jacobsen, S. J.
- Affiliations
- Kaiser Permanente (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Sim, John J.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 88
- Issue
- 3
- Pages
- 622-632
- ISSN
- 0085-2538 (ISSN-L)
- PMC
- PMC4556588
- OpenAlex
- W1544563963
- Cited by
- 238
- References
- 55
- Citations by year
- 2026: 29 · 2025: 23 · 2024: 23 · 2023: 29 · 2022: 22 · 2021: 18 · 2020: 27 · 2019: 16 · 2018: 18 · 2017: 16 · 2016: 11 · 2015: 4
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Kaiser Permanente
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK091419)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- resistant hypertension, uncontrolled hypertension, controlled hypertension, end-stage renal disease, congestive heart failure, stroke, all-cause mortality, cardiovascular risk, sex differences, Hispanic origin, chronic kidney disease
- MeSH terms
- Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Cerebrovascular Disorders, Drug Resistance, Female, Heart Failure, Humans, Hypertension, Kidney Failure, Chronic, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Multivariate Analysis, Chi-Square Distribution, Proportional Hazards Models, Treatment Outcome, Myocardial Ischemia, Risk Assessment, Disease-Free Survival, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
